Drug Approval | October 04, 2021
Lilly to transfer rights of two diabetes drugs to Cipla in India
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
Torrent is one of India's fastest-growing pharma majors
The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
A total of 707 district hospitals across all states and union territories participated in the performance assessment. The Health Management Information System (HMIS) data for the year 2017–18 has been used as a baseline for this exercise
TCS to help Apoteket drive its digital transformation across sales channels and internal processes
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
As part of this strategic partnership, LTI with its digital, technical and life sciences domain capabilities, will help accelerate joint go-to-market pursuits and faster deployment for Clinpal Adopters
The investment will increase SpeeDx internal capacity to scale up manufacturing
This project will be conducted at the “NURA,” a health screening centre that Fujifilm opened in India in February this year
The company does not expect the outcome of this inspection to impact its plans
Subscribe To Our Newsletter & Stay Updated
